US digital pathology market was valued at $515.5 million in 2025 and is projected to reach $3,387.5 million by 2035, growing at a CAGR of 20.8% during the forecast period (2026–2035). In the US digital pathology market, cloud-based solutions are increasingly adopted to manage the growing volume and complexity of pathology data. These platforms provide scalable infrastructure that reduces reliance on on-premise systems and supports efficient data storage and retrieval. Cloud deployment enables remote access to digital slides, facilitating collaboration among pathologists across geographically distributed healthcare facilities. It also supports integration with artificial intelligence tools used for image analysis and decision support. Subscription-based models associated with cloud platforms offer greater flexibility in cost management for healthcare organizations. Overall, cloud-based digital pathology aligns with the operational and analytical needs of multi-site health systems.
Browse the full report description of “US Digital Pathology Market Size, Share & Trends Analysis Report by Product (Scanner Device, Software and Storage System), by Application (Teleconsultation, Disease Diagnosis and Drug Discovery and Other) and by End-User (Biotechnology & Pharmaceutical Companies, Hospitals and Others), Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/us-digital-pathology-market
Major healthcare organizations are transforming pathology service delivery through the adoption of digital technologies. As it enable faster case review, streamlined slide sharing, and reduced dependence on physical specimen transport. In August 2025, FUJIFILM Healthcare Americas Corporation announced that a leading East Coast health system spanning five regions has selected its Synapse Pathology solution powered by Amazon Web Services (AWS) to digitize pathology operations. The cloud-based, first-of-its-kind North American deployment integrates with Epic Beaker to accelerate diagnoses, streamline workflows, and support enterprise-wide digital transformation across all five hospital sites.
Recent Innovations in the US Digital Pathology Market
The major companies operating in the US digital pathology market include F. Hoffmann-La Roche Ltd., Leica Biosystems, Nussloch GmbH, Philips N.V., Hamamatsu Photonics K.K., and Indica Labs LLC, among others. These major players are focusing on developing advanced digital pathology solutions, expanding cloud-based platforms, and integrating AI-powered analytics to enhance diagnostic accuracy, workflow efficiency, and enterprise-wide adoption across hospitals and laboratories in the US.
Market Coverage
Key questions addressed by the report.
US Digital Pathology Market Report Segment
By Product Type
By Application
By End-User
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-digital-pathology-market